Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection

Anti-hepatitis C virus (HCV) treatment for human immunodeficiency virus (HIV)/HCV co-positive patients with hemophilia A presents numerous problems in terms of safety and effectiveness. The emergence of direct-acting antiviral (DAA) regimens has led to tremendous changes in the management of HIV/HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Hong, Chen, Jun, Wang, Jiangrong, Li, Juhua, Yang, Feia, Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708971/
https://www.ncbi.nlm.nih.gov/pubmed/31348267
http://dx.doi.org/10.1097/MD.0000000000016524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708971/
https://www.ncbi.nlm.nih.gov/pubmed/31348267
http://dx.doi.org/10.1097/MD.0000000000016524

Ejemplares similares